Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02517554

NCT02517554
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are an adult aged 18 or older
  • You can understand and communicate in English
  • You meet certain national guidelines that say you should be considered for genetic testing related to breast, ovarian, or colorectal cancer (confirm with trial site)
  • You have health insurance that covers genetic testing

Who may not be able to join:

  • You are under 18 years old, as guidelines do not recommend this type of genetic cancer risk testing for minors
  • You do not speak or understand English
  • You do not have health insurance that covers genetic testing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Abramson Cancer Center at Penn Medicine
Registry
clinicaltrials_gov
Start date
1 August 2015
Est. completion
1 March 2018

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Completion of Surveys

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov